紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2024 – Oct 2025Where it's discussed
-
News14 articles
-
X / Twitter7 posts
-
YouTube2 videos
AI synopsis
What people are saying
Discussions reflect a cautious curiosity, with some posts highlighting the LDL-lowering benefits of red yeast rice, such as 'significant LDL decrease,' while others question safety and call for more research, evidenced by phrases like 'safety is uncertain' and 'more reliable studies needed.' The tone oscillates between cautious optimism and concern, demonstrating moderate engagement driven by safety considerations and potential benefits.
The discussions show a neutral stance overall, with some acknowledging LDL reduction but expressing caution due to safety concerns.
Participants are somewhat interested, focusing on safety and effectiveness, indicating a moderate level of engagement with the topic.
Respondents are engaging by sharing opinions and aspects of the study, though not deeply analyzing methodologies or broader implications.
The collective discussion suggests limited immediate impact, mainly raising questions about safety rather than driving urgent change or adoption.
Abstract in brief
- Traditional Chinese red yeast rice (RYR) significantly reduces LDL cholesterol levels, with an average decrease of around 0.102 mmol/L, and its effect is comparable to statin therapy.
- The safety of RYR is uncertain; most studies had low quality in safety assessments, but the incidence of liver and kidney injury was low (about 0.5%) and similar to placebo or control groups.
- More reliable studies are needed to confirm RYR’s safety profile, but it could be a safe and effective option for patients who cannot tolerate statins.
Top posts
Most liked on X and Blueskyhttps://t.co/6aXS58HZVV
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
All mentions
Impact of Fish Oil Supplements on Cardiovascular Health
This video discusses a study analyzing how fish oil supplements impact cardiovascular disease progression. It highlights significant findings from a cohort of over 415,000 participants, showing benefits in reducing…
Natural Red Yeast Rice for Effective Cholesterol Reduction
Learn how red yeast rice, a natural supplement rich in monacolin K, can significantly reduce LDL cholesterol levels. Although promising, safety assessments are limited, and more research is needed to confirm its safety…
https://t.co/6aXS58HZVV
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm
真
S
AA
TM
し
狢富
ガ